カレントテラピー　34-12　サンプル page 10/36

このページは カレントテラピー　34-12　サンプル の電子ブックに掲載されている10ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　34-12　サンプル

Current Therapy 2016 Vol.34 No.12 13過活動膀胱の診断と治療1147between vascular risk factors and lower urinary tract symptomsin both sexes. Eur Urol 50：581-586, 200616）Mitterberger M, Pallwein L, Gradl J, et al：Persistent detrusoroveractivity after transurethral resection of the prostateis associated with reduced perfusion of the urinary bladder.BJU Int 99：831-835, 200717）横山　修：膀胱血流障害による膀胱壁内神経の変性に関する実験的研究．日泌尿会誌 79：436-444, 198818）Azadzoi KM, Tarcan T, Kozlowski R, et al：Overactivity andstructural changes in the chronically ischemic bladder. J Urol162：1768-1778, 199919）Yoshida M, Masunaga K, Nagata T, et al：The effects ofchronic hyperlipidemia on bladder function in myocardialinfarction-prone Watanabe heritable hyperlipidemic（WHHLMI）rabbits. Neurouol Urodyn 29：1350-1354, 201020）Nomiya M, Yamaguchi O, Andersson KE, et al：The effect ofatherosclerosis-induced chronic bladder ischemia on bladderfunction in the rat. Neurourol Urodyn 31：195-200, 201221）Yono M, Yamamoto Y, Yoshida M, et al：Effects of doxazosinon blood flow and mRNA expression of nitric oxide synthasein the spontaneously hypertensive rat genitourinary tract.Life Sci 81：218-222, 200722）Shimizu S, Saito M, Oiwa H, et al：Olmesartan amelioratesurinary dysfunction in the spontaneously hypertensive ratvia recovering bladder blood flow and decreasing oxidativestress. Neurourol Urodyn 33：350-357, 201423）Ito H, Taga M, Tsuchiyama K, et al：IPSS is lower in hypertensivepatients treated with angiotensin-Ⅱ receptor blocker：posthoc analyses of a lower urinary tract symptoms population.Neurourol Urodyn 32：70-74, 201324）Vikram A, Jena GB, Romarao P：Increased cell proliferationand contractility of prostate in insulin resistant rats：linkinghyperinsulinemia with benign prostate hyperplasia. Prostate70：79-89, 201025）Golomb E, Rosenzweig N, Eilam R, et al：Spontaneous hyperplasiaof the ventral lobe of the prostate in aging geneticallyhypertensive rats. J Androl 21：58-64, 200026）Daly DM, Nocchi L, Liaskos M, et al：Age-related changesin afferent pathways and urothelial function in the malemouse bladder. J Physiol 592：537-549, 201427）Apostolidis A, Jacques TS, Freeman A, et al：Histologicalchanges in the urothelium and suburothelium of human overactivebladder following intradetrusor injections of botulinumneurotoxin type A for the treatment of neurogenic or idiopathicdetrusor overactivity. Eur Urol 53：1245-1253, 200828）Chung SD, Liu HT, Lin H, et al：Elevation of serum C-reactiveprotein in patients with OAB and IC/BPS implies chronicinflammation in the urinary bladder. Neurourol Urodyn30：417-420, 201129）Hextall A, Bidmead J, Cardozo L, et al：The impact of themenstrual cycle on urinary symptoms and the results of urodynamicinvestigation. BJOG 108：1193-1196, 200130）Robinson D, Toozs-Hobson P, Cardozo L：The effect of hormoneson the lower urinary tract. Menopause Int 19：155-162, 201331）Tegerstedt G, Maehle-Schmidt M, Nyren O, et al：Prevalenceof symptomatic pelvic organ prolapse in a Swedishpopulation. Int Urogynecol J Pelvic Floor Dysfunct 16：497-503, 200532）Coates KW, Harris RL, Cundiff GW, et al：Uroflowmetry inwomen with urinary incontinence and pelvic organ prolapse.Br J Urol 80：217-221, 199733）Jung SY, Fraser MO, Ozawa H, et al：Urethral afferentnerve activity affects the micturition reflex；implication forthe relationship between stress incontinence and detrusorinstability. J Urol 162：204-212, 199934）Azadzoi KM, Radisavljevic ZM, Golabek T, et al：Oxidativemodification of mitochondrial integrity and nerve fiber densityin the ischemic overactive bladder. J Urol 183：362-369,201035）Drake MJ, Harvey IJ, Gillespie JI, et al：Localized contractionsin the normal human bladder and in urinary urgency.BJU Int 95：1002-1005, 200536）Christ GJ, Day NS, Day M, et al：Increased connexin43-mediated intercellular communication in a rat model of bladderoveractivity in vivo. Am J Physiol Regul Integr CompPhysiol 284：R1241-R1248, 200337）Birder LA, de Groat WC：Mechanisms of disease：involvementof the urothelium in bladder dysfunction. Nat ClinPract Urol 4：46-54, 200738）Yokoyama O, Yusup A, Oyama N, et al：Improvement ofbladder storage function by tamusulosin depends on suppressionof C-fiber urethral afferent activity in rats. J Urol 177：771-775, 200739）Akishita M, Hashimoto M, Ohike Y, et al：Low testosteronelevel is an independent determinant of endothelial dysfunctionin men. Hypertens Res 30：1029-1034, 200740）Tek M, Balli E, Cimen B, et al：The effect of testosteronereplacement therapy on bladder functions and histology inorchiectomized mature male rats. Urology 75：886-890, 201041）Amano T, Imao T, Takemae K, et al：Testosterone replacementtherapy by testosterone ointment relieves lower urinarytract symptoms in late onset hypogonadism patients.Aging Male 13：242-246, 2010